C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-γ are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells

Journal of Immunology

Volumn 178, Issue 11, 2007, Pages 7072-7080

  Wang, Wei ^a   Milani, Monica ^a   Ostlie, Norma ^a   Okita, David ^a   Agarwal, Rajeev K ^b   Caspi, Rachel ^b   Conti Fine, Bianca M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLINERGIC RECEPTOR; COMPLEMENT; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EFFECTOR CELL; FEMALE; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; MYASTHENIA GRAVIS; NATURAL KILLER T CELL; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYMPTOMATOLOGY; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

EID: 34249829243     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.11.7072     Document Type: Article

References (43)

1. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
2. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573.
3. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
4. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
5. Conti-Fine, B. M., M. Protti, M. Bellone, and J. F. Howard. 1997. Myasthenia Gravis: The Immunobiology of an Autoimmune Disease. R. G. Landes, Austin, TX.
6. Conti-Fine, B. M., B. Diethem-Okita, N. Ostlie, W. Wang, and M. Milani. 2003. Immunopathogenesis of myasthenia gravis. Myasthenia Gravis and Related Disorders. Humana, Totowa, NJ, pp. 53-92.
7. Berman, P. W., and J. Patrick. 1980. Experimental myasthenia gravis: a murine system. J. Exp. Med. 151: 204-223.
8. Lennon, V. A., J. M. Lindstrom, and M. E. Seybold. 1975. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 141: 1365-1375.
9. Moiola, L., F. Galbiati, G. Martino, S. Amadio, E. Brambilla, G. Comi, A. Vincent, L. M. Grimaldi, and L. Adorini. 1998. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur. J. Immunol. 28: 2487-2497.
10. -/- BALB/c mice suggests a pathogenic role of Th1 cells. J. Immunol. 172: 97-103.
11. Karachunski, P. I., N. S. Ostlie, C. Monfardini, and B. M. Conti-Fine. 2000. Absence of IFN-γ or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. J. Immunol. 164: 5236-5244.
12. Balasa, B., C. Deng, J. Lee, L. M. Bradley, D. K. Dalton, P. Christadoss, and N. Sarvetnick. 1997. Interferony (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med. 186: 385-391.
13. Zhang, G. X., B. G. Xiao, X. F. Bai, P. H. van der Meide, A. Orn, and H. Link. 1999. Mice with IFN-γ receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. J. Immunol. 162: 3775-3781.
14. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177.
15. Rohn, T. A., G. T. Jennings, M. Hernandez, P. Grest, M. Beck, Y. Zou, M. Kopf, and M. F. Bachmann. 2006. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 36: 2857-2867.
16. Veldhoen, M., and B. Stockinger. 2006. TGFβ1, a "Jack of all trades"; the link with pro-inflammatory IL-17-producing T cells. Trends Immunol. 27: 358-361.
17. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
18. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
19. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 4: 471-481.
20. + cells sensitized to nicotinic acetylcholine receptor. J. Immunol. 147: 1484-1491.
21. Karachunski, P. I., N. S. Ostlie, D. K. Okita, and B. M. Conti-Fine. 1997. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J. Clin. Invest. 100: 3027-3035.
22. Ostlie, N., M. Milani, W. Wang, D. Okita, and B. M. Conti-Fine. 2003. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice. J. Immunol. 170: 604-612.
23. + epitope sequences of the acetylcholine receptor. J. Neuroimmunol. 95: 73-84.
24. Monfardini, C., M. Milani, N. Ostlie, W. Wang, P. I. Karachunski, D. K. Okita, J. Lindstrom, and B. M. Conti-Fine. 2002. Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes. J. Neuroimmunol. 123: 123-134.
25. Bellone, M., N. Ostlie, S. Lei, and B. M. Conti-Tronconi. 1991. Experimental myasthenia gravis in congenic mice: sequence mapping and H-2 restriction of T helper epitopes on the α subunits of Torpedo californica and murine acetylcholine receptors. Eur. J. Immunol. 21: 2303-2310.
26. Infante, A. J., P. A. Thompson, K. A. Krolick, and K. A. Wall. 1991. Determinant selection in murine experimental autoimmune myasthenia gravis: effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. J. Immunol. 146: 2977-2982.
27. Crispin, J. C., M. I. Vargas, and J. Alcocer-Varela. 2004. Immunoregulatory T cells in autoimmunity. Autoimmun. Rev. 3: 45-51.
28. + T cells. Microbes Infect. 3: 919-927.
29. Ziegler, S. F. 2006. Foxp3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
30. Beissert, S., A. Schwarz, and T. Schwarz. 2006. Regulatory T cells. J. Invest. Dermatol. 126: 15-24.
31. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
32. + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199: 25-34.
33. + regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ. Arthritis Res. Ther. 7: R402-R415.
34. Sawitzki, B., C. I. Kingsley, O. V. M. Karim, M. Herber, and K. J. Wood. 2005. IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201: 1925-1935.
35. + T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105: 735-741.
36. + T cells in myasthenia gravis patients with stability and thymectomy. Clin. Immunol. 112: 284-289.
37. Shi, F. D., H. B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, and H. G. Ljunggren. 2000. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1: 245-251.
38. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune reglation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
39. Margalit, M., and Y. Ilan. 2005. Induction of immune tolerance: a role for natural killer T lymphocytes? Liver Int. 25: 501-504.
40. + T regulatory cells in the prevention of autoimmune myasthenia. J. Immunol. 175: 7898-7904.
41. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gumey. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914.
42. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
43. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-β induces development of the Th17 lineage. Nature 441: 231-234.